At the time of writing, Mastec Inc. [MTZ] stock is trading at $92.38, up 0.98%. An important factor to consider is whether the stock is rising or falling in short-term value. The MTZ shares have gain 8.87% over the last week, with a monthly amount glided 34.57%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 29, February 2024, MasTec Announces Fourth Quarter and Annual 2023 Financial Results and Provides Initial 2024 Guidance. In a post published today on Yahoo Finance, Record Fourth Quarter and Annual Revenue of $3.3 Billion and $12.0 Billion, Respectively.
From an analyst’s perspective:
Mastec Inc. [NYSE: MTZ] stock has seen the most recent analyst activity on March 04, 2024, when Craig Hallum upgraded its rating to a Buy and also boosted its price target to $96 from $50. Previously, TD Cowen reaffirmed its Outperform rating on March 04, 2024, and elevated its price target to $105. On January 16, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $75 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $92 on January 10, 2024. Stifel initiated its recommendation with a Buy and recommended $70 as its price target on November 16, 2023. Goldman downgraded its rating to Neutral for this stock on November 08, 2023, but kept the price target unchanged to $54. In a note dated November 02, 2023, Craig Hallum downgraded an Hold rating on this stock but restated the target price of $50.
For the past year, the stock price of Mastec Inc. fluctuated between $44.65 and $123.33. Currently, Wall Street analysts expect the stock to reach $102.67 within the next 12 months. Mastec Inc. [NYSE: MTZ] shares were valued at $92.38 at the most recent close of the market. An investor can expect a potential return of 11.14% based on the average MTZ price forecast.
Analyzing the MTZ fundamentals
According to Mastec Inc. [NYSE:MTZ], the company’s sales were 12.00B for trailing twelve months, which represents an 9.03% jump. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 91.57 points at the first support level, and at 90.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.34, and for the 2nd resistance point, it is at 94.29.
Mastec Inc. [MTZ] reported earnings per share of $0.66 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.44/share, meaning a difference of $0.22 and a surprise factor of 50.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.95 per share as compared to estimates of $1.84 per share, a difference of -$0.89 representing a surprise of -48.40%.
Ratios To Look Out For
It is important to note that Mastec Inc. [NYSE:MTZ] has a current ratio of 1.40. On the other hand, the Quick Ratio is 1.36, and the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 0.61, the price to book ratio is 2.71.
Transactions by insiders
Recent insider trading involved DiMarco Paul, CFO, that happened on Oct 02 ’23 when 1332.0 shares were sold. CAO, Love Timothy Michael completed a deal on Oct 02 ’23 to sell 1095.0 shares.
